Pharmacoeconomics

Eradication of Helicobacter pylori offers the potential of cost savings in combination with better outcomes over intermittent or maintenance therapy of duodenal ulcer disease. Treatment regimes that give a higher eradication rate are cost-effective despite higher costs. In the same way, an early eradication policy is more cost-effective than delayed management. Studies comparing empirical therapy with initial endoscopy show very different expected costs for patient management and the conclusions are conflicting.SCOPUS: sh.j